IPESX
Price
$5.40
Change
-$0.02 (-0.37%)
Updated
Oct 7 closing price
Net Assets
517.59M
RMFCX
Price
$62.10
Change
-$0.10 (-0.16%)
Updated
Oct 7 closing price
Net Assets
112.6B
Interact to see
Advertisement

IPESX vs RMFCX

Header iconIPESX vs RMFCX Comparison
Open Charts IPESX vs RMFCXBanner chart's image
Voya Large Cap Value Port S
Price$5.40
Change-$0.02 (-0.37%)
VolumeN/A
Net Assets517.59M
American Funds American Mutual R3
Price$62.10
Change-$0.10 (-0.16%)
VolumeN/A
Net Assets112.6B
IPESX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
IPESX vs. RMFCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPESX is a StrongBuy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 113B vs. IPESX (518M). IPESX pays higher dividends than RMFCX: IPESX (1.41) vs RMFCX (1.20). IPESX was incepted earlier than RMFCX: IPESX (18 years) vs RMFCX (23 years). IPESX (1.12) is less costly to investors than RMFCX (0.91). IPESX is a more actively managed with annual turnover of: 101.00 vs. RMFCX (31.00). IPESX has a lower initial minimum investment than RMFCX: IPESX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 8.11 vs. IPESX (-8.62). RMFCX return over 5 years is better than : 59.28 vs. IPESX (-40.99).
IPESXRMFCXIPESX / RMFCX
Total Expense Ratio0.940.91103%
Annual Report Gross Expense Ratio1.120.91123%
Fund Existence18 years23 years-
Gain YTD-8.87014.779-60%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets518M113B0%
Annual Yield % from dividends1.411.20117%
Returns for 1 year-8.628.11-106%
Returns for 3 years24.2343.6156%
Returns for 5 years-40.9959.28-69%
Returns for 10 years-41.5493.90-44%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO8.341.87
+28.90%
Lexeo Therapeutics
FRMEP25.74-0.06
-0.23%
First Merchants Corp
VMI397.23-3.13
-0.78%
Valmont Industries
UFPT196.98-4.95
-2.45%
UFP Technologies
KPTI5.77-0.39
-6.33%
Karyopharm Therapeutics Inc.